Ascletis Pharma Inc. announces that Shanghai Public Health Clinical Center presented clinical results of ASC22 in combination with Chidamide for functional cure of human immunodeficiency virus infection at the 12th International AIDS Society Conference on HIV Science in Brisbane, Australia, and virtually.
